{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:06Z","timestamp":1792782726244,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Salerno","id":[{"id":"https:\/\/ror.org\/0192m2k53","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Televisits are a valuable tool for Parkinson\u2019s disease (PD) follow-up; however, their implementation is hindered by a fragmented evidence base. This narrative review synthesizes 41 articles (31 observational, 10 comparative) spanning three decades, categorizing findings into three domains:\n                    <jats:italic>feasibility<\/jats:italic>\n                    ,\n                    <jats:italic>clinical outcomes<\/jats:italic>\n                    , and\n                    <jats:italic>efficiency<\/jats:italic>\n                    . Results indicate high feasibility with visit completion frequently exceeding 70% and high user satisfaction primarily due to reduced travel burden and costs. Clinical outcomes appear comparable to in-person care, yet evidence on efficiency remains inconclusive. Current literature suffers from methodological limitations, including small sample sizes, U.S. geographic bias, and a lack of standardized outcome taxonomies. Notably, we identify a recurring \u201caugmentation bias\u201d in comparative trial designs: experimental arms frequently receive more clinical attention than controls. This suggests that reported benefits may derive from increased care frequency rather than the specific care delivery modality, questioning the cost-effectiveness of such resource-heavy models in routine practice. Furthermore, barriers regarding the digital divide and concerns about international privacy regulations (e.g., GDPR\/HIPAA) remain unresolved. In conclusion, televisits should be integrated into validated hybrid frameworks rather than serving as standalone replacements. To advance the field, research must pivot from basic feasibility toward establishing standardized outcome measures and proving long-term economic sustainability in real-world clinical settings.\n                  <\/jats:p>","DOI":"10.1007\/s00702-026-03238-5","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:47:14Z","timestamp":1784980034000},"page":"2129-2151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Televisits for Parkinson\u2019s disease: benefits and barriers"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-0157","authenticated-orcid":false,"given":"V.","family":"Canoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4052-8073","authenticated-orcid":false,"given":"C.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1357-6825","authenticated-orcid":false,"given":"M.","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-2504","authenticated-orcid":false,"given":"P.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-7419","authenticated-orcid":false,"given":"R.","family":"Erro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"3238_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.parkreldis.2012.10.008","volume":"19","author":"A Abdolahi","year":"2013","unstructured":"Abdolahi A, Scoglio N, Killoran A et al (2013) Potential reliability and validity of a modified version of the Unified Parkinson\u2019s Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord 19:218\u2013221. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.10.008","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR2","doi-asserted-by":"publisher","unstructured":"Barbour PJ, Arroyo J, High S et al (2016) Telehealth for patients with Parkinson\u2019s disease: delivering efficient and sustainable long-term care. Hosp Pract 1995 44:92\u201397. https:\/\/doi.org\/10.1080\/21548331.2016.1166922","DOI":"10.1080\/21548331.2016.1166922"},{"issue":"3","key":"3238_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/JBIES-22-00430","volume":"21","author":"TH Barker","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, Aromataris E, Munn Z (2023) The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synthesis 21(3):494\u2013506","journal-title":"JBI Evid Synthesis"},{"issue":"3","key":"3238_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.11124\/JBIES-24-00523","volume":"24","author":"TH Barker","year":"2026","unstructured":"Barker TH, Hasanoff S, Aromataris E, Stone JC, Leonardi-Bee J, Sears K et al (2026) The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies. JBI Evid Synth 24(3):401\u2013408","journal-title":"JBI Evid Synth"},{"key":"3238_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1089\/tmj.2014.9981","volume":"20","author":"RL Bashshur","year":"2014","unstructured":"Bashshur RL, Shannon GW, Smith BR et al (2014) The empirical foundations of telemedicine interventions for chronic disease management. Telemed J E-Health Off J Am Telemed Assoc 20:769\u2013800. https:\/\/doi.org\/10.1089\/tmj.2014.9981","journal-title":"Telemed J E-Health Off J Am Telemed Assoc"},{"key":"3238_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1212\/WNL.0000000000004357","volume":"89","author":"CA Beck","year":"2017","unstructured":"Beck CA, Beran DB, Biglan KM et al (2017) National randomized controlled trial of virtual house calls for Parkinson disease. Neurology 89:1152\u20131161. https:\/\/doi.org\/10.1212\/WNL.0000000000004357","journal-title":"Neurology"},{"key":"3238_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/jcm11041074","volume":"11","author":"J Bendig","year":"2022","unstructured":"Bendig J, Wolf A-S, Mark T et al (2022) Feasibility of a Multimodal Telemedical Intervention for Patients with Parkinson\u2019s Disease-A Pilot Study. J Clin Med 11:1074. https:\/\/doi.org\/10.3390\/jcm11041074","journal-title":"J Clin Med"},{"key":"3238_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/acn3.412","volume":"4","author":"KM Biglan","year":"2017","unstructured":"Biglan KM, Oakes D, Lang AE et al (2017) A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III). Ann Clin Transl Neurol 4:360\u2013368. https:\/\/doi.org\/10.1002\/acn3.412","journal-title":"Ann Clin Transl Neurol"},{"key":"3238_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","volume":"36","author":"DJ Bowen","year":"2009","unstructured":"Bowen DJ, Kreuter M, Spring B et al (2009) How we design feasibility studies. Am J Prev Med 36:452\u2013457. https:\/\/doi.org\/10.1016\/j.amepre.2009.02.002","journal-title":"Am J Prev Med"},{"key":"3238_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/pmrj.12001","volume":"11","author":"I Cabrera-Martos","year":"2019","unstructured":"Cabrera-Martos I, Ortiz-Rubio A, Torres-S\u00e1nchez I et al (2019) Agreement Between Face-to-Face and Tele-assessment of Upper Limb Functioning in Patients with Parkinson Disease. PM R 11:590\u2013596. https:\/\/doi.org\/10.1002\/pmrj.12001","journal-title":"PM R"},{"key":"3238_CR11","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/mdc3.70171","volume":"12","author":"V Canoro","year":"2025","unstructured":"Canoro V, Pilotto A, Lena F et al (2025) Digital Inclusion in Parkinson\u2019s Disease: A Case-Control Study. Mov Disord Clin Pract 12:1873\u20131881. https:\/\/doi.org\/10.1002\/mdc3.70171","journal-title":"Mov Disord Clin Pract"},{"key":"3238_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40801-023-00410-1","volume":"11","author":"KR Chaudhuri","year":"2024","unstructured":"Chaudhuri KR, Azulay J-P, Odin P et al (2024) Economic Burden of Parkinson\u2019s Disease: A Multinational, Real-World, Cost-of-Illness Study. Drugs - Real World Outcomes 11:1\u201311. https:\/\/doi.org\/10.1007\/s40801-023-00410-1","journal-title":"Drugs - Real World Outcomes"},{"key":"3238_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.parkreldis.2020.05.038","volume":"75","author":"R Cilia","year":"2020","unstructured":"Cilia R, Mancini F, Bloem BR, Eleopra R (2020) Telemedicine for parkinsonism: A two-step model based on the COVID-19 experience in Milan, Italy. Parkinsonism Relat Disord 75:130\u2013132. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.05.038","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR14","doi-asserted-by":"publisher","first-page":"e16561","DOI":"10.1111\/ene.16561","volume":"32","author":"E Cubo","year":"2025","unstructured":"Cubo E, Rohani M, Eissazade N et al (2025) Cost-utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson\u2019s disease. Eur J Neurol 32:e16561. https:\/\/doi.org\/10.1111\/ene.16561","journal-title":"Eur J Neurol"},{"key":"3238_CR15","doi-asserted-by":"publisher","first-page":"237437352199722","DOI":"10.1177\/2374373521997224","volume":"8","author":"W Deeb","year":"2021","unstructured":"Deeb W, Hess CW, Gamez N et al (2021) Response to Telemedicine Visits From Patients With Parkinsonism During the COVID-19 Pandemic on Postvisit Surveys. J Patient Exp 8:2374373521997224. https:\/\/doi.org\/10.1177\/2374373521997224","journal-title":"J Patient Exp"},{"key":"3238_CR18","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/mds.23145","volume":"25","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Deuel LM, Voss TS et al (2010) Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson\u2019s disease. Mov Disord 25:1652\u20131659. https:\/\/doi.org\/10.1002\/mds.23145","journal-title":"Mov Disord"},{"key":"3238_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamaneurol.2013.123","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey ER, Venkataraman V, Grana MJ et al (2013) Randomized controlled clinical trial of virtual house calls for Parkinson disease. JAMA Neurol 70:565\u2013570. https:\/\/doi.org\/10.1001\/jamaneurol.2013.123","journal-title":"JAMA Neurol"},{"key":"3238_CR17","doi-asserted-by":"publisher","first-page":"205520761559299","DOI":"10.1177\/2055207615592998","volume":"1","author":"ER Dorsey","year":"2015","unstructured":"Dorsey ER, Darwin KC, Mohammed S et al (2015a) Virtual research visits and direct-to-consumer genetic testing in Parkinson\u2019s disease. Digit Health 1:2055207615592998. https:\/\/doi.org\/10.1177\/2055207615592998","journal-title":"Digit Health"},{"key":"3238_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3233\/JPD-150549","volume":"5","author":"ER Dorsey","year":"2015","unstructured":"Dorsey ER, Wagner JD, Bull MT et al (2015b) Feasibility of Virtual Research Visits in Fox Trial Finder. J Park Dis 5:505\u2013515. https:\/\/doi.org\/10.3233\/JPD-150549","journal-title":"J Park Dis"},{"key":"3238_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/tmj.2015.0191","volume":"22","author":"ER Dorsey","year":"2016","unstructured":"Dorsey ER, Achey MA, Beck CA et al (2016) National Randomized Controlled Trial of Virtual House Calls for People with Parkinson\u2019s Disease: Interest and Barriers. Telemed J E-Health Off J Am Telemed Assoc 22:590\u2013598. https:\/\/doi.org\/10.1089\/tmj.2015.0191","journal-title":"Telemed J E-Health Off J Am Telemed Assoc"},{"key":"3238_CR19","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The Emerging Evidence of the Parkinson Pandemic. J Park Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Park Dis"},{"key":"3238_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/mdc3.12436","volume":"4","author":"G Durner","year":"2017","unstructured":"Durner G, Durner J, Dunsche H et al (2017) 24\/7 Live Stream Telemedicine Home Treatment Service for Parkinson\u2019s Disease Patients. Mov Disord Clin Pract 4:368\u2013373. https:\/\/doi.org\/10.1002\/mdc3.12436","journal-title":"Mov Disord Clin Pract"},{"key":"3238_CR23","doi-asserted-by":"publisher","first-page":"e001000","DOI":"10.1136\/bmjoq-2020-001000","volume":"9","author":"L Evans","year":"2020","unstructured":"Evans L, Mohamed B, Thomas EC (2020) Using telemedicine and wearable technology to establish a virtual clinic for people with Parkinson\u2019s disease. BMJ Open Qual 9:e001000. https:\/\/doi.org\/10.1136\/bmjoq-2020-001000","journal-title":"BMJ Open Qual"},{"key":"3238_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-03062-3","author":"B Falkenburger","year":"2025","unstructured":"Falkenburger B, Fanciulli A, P\u00f6tter-Nerger M et al (2025) Clinical utility of digital technologies in Parkinson\u2019s disease. J Neural Transm Vienna Austria 1996. https:\/\/doi.org\/10.1007\/s00702-025-03062-3","journal-title":"J Neural Transm Vienna Austria 1996"},{"key":"3238_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2022.07.017","volume":"102","author":"JE Fleisher","year":"2022","unstructured":"Fleisher JE, Hess SP, Klostermann EC et al (2022) IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson\u2019s disease. Parkinsonism Relat Disord 102:68\u201376. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.07.017","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR26","doi-asserted-by":"publisher","first-page":"107215","DOI":"10.1016\/j.parkreldis.2024.107215","volume":"130","author":"\u00c1 Garc\u00eda-Bustillo","year":"2025","unstructured":"Garc\u00eda-Bustillo \u00c1, Ram\u00edrez-Sanz JM, Garrido-Labrador JL et al (2025a) A multidisciplinary telemedicine approach for managing frailty in Parkinson\u2019s disease. A longitudinal, case-control study. Parkinsonism Relat Disord 130:107215. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107215","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70314","author":"\u00c1 Garc\u00eda-Bustillo","year":"2025","unstructured":"Garc\u00eda-Bustillo \u00c1, Youn J, Ahn JH et al (2025b) The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson\u2019s Disease in Different World Regions. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70314","journal-title":"Mov Disord Clin Pract"},{"key":"3238_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"3238_CR29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","author":"GBD 2023 Disease and Injury and Risk Factor Collaborators","year":"2025","unstructured":"GBD 2023 Disease and Injury and Risk Factor Collaborators (2025) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Lond Engl 406:1873\u20131922. https:\/\/doi.org\/10.1016\/S0140-6736(25)01637-X","journal-title":"Lancet Lond Engl"},{"key":"3238_CR30","unstructured":"GDPR (2016) Regulation (EU) 2016\/679 (General Data Protection Regulation)"},{"key":"3238_CR31","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2021.0474","author":"S Ghourchian","year":"2022","unstructured":"Ghourchian S, Torres-Yaghi YA, Isaacson SH et al (2022) Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic. Telemed J E-Health Off J Am Telemed Assoc. https:\/\/doi.org\/10.1089\/tmj.2021.0474","journal-title":"Telemed J E-Health Off J Am Telemed Assoc"},{"key":"3238_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-022-01026-1","volume":"22","author":"J Greiwe","year":"2022","unstructured":"Greiwe J (2022) Telemedicine Lessons Learned During the COVID-19 Pandemic. Curr Allergy Asthma Rep 22:1\u20135. https:\/\/doi.org\/10.1007\/s11882-022-01026-1","journal-title":"Curr Allergy Asthma Rep"},{"key":"3238_CR34","doi-asserted-by":"publisher","first-page":"e183517","DOI":"10.1001\/jamanetworkopen.2018.3517","volume":"1","author":"PW Groeneveld","year":"2018","unstructured":"Groeneveld PW (2018) Measuring and Improving the Value of Hospital Care. JAMA Netw Open 1:e183517. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3517","journal-title":"JAMA Netw Open"},{"key":"3238_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/mdc3.12703","volume":"6","author":"RE Hanson","year":"2019","unstructured":"Hanson RE, Truesdell M, Stebbins GT et al (2019) Telemedicine vs Office Visits in a Movement Disorders Clinic: Comparative Satisfaction of Physicians and Patients. Mov Disord Clin Pract 6:65\u201369. https:\/\/doi.org\/10.1002\/mdc3.12703","journal-title":"Mov Disord Clin Pract"},{"key":"3238_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000475801","volume":"1","author":"DA Heldman","year":"2017","unstructured":"Heldman DA, Harris DA, Felong T et al (2017) Telehealth Management of Parkinson\u2019s Disease Using Wearable Sensors: An Exploratory Study. Digit Biomark 1:43\u201351. https:\/\/doi.org\/10.1159\/000475801","journal-title":"Digit Biomark"},{"key":"3238_CR37","unstructured":"HIPAA (1996) Health Insurance Portability and Accountability Act of 1996"},{"key":"3238_CR38","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.prdoa.2024.100296","volume":"12","author":"SH Hong","year":"2025","unstructured":"Hong SH, Kim S, Lee S et al (2025) Hospital utilization and telemedicine preferences in patients with late-stage Parkinson\u2019s disease and caregivers. Clin Park Relat Disord 12:100296. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100296","journal-title":"Clin Park Relat Disord"},{"issue":"3","key":"3238_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/tmj.2021.0117","volume":"28","author":"E Houston","year":"2022","unstructured":"Houston E, Kennedy AG, O\u2019Malley D, Rabinowitz T, Rose GL, Boyd J (2022) Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders. Telemedicine E-Health 28(3):295\u2013308. https:\/\/doi.org\/10.1089\/tmj.2021.0117","journal-title":"Telemedicine E-Health"},{"key":"3238_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/mds.870080326","volume":"8","author":"JP Hubble","year":"1993","unstructured":"Hubble JP, Pahwa R, Michalek DK et al (1993) Interactive video conferencing: a means of providing interim care to Parkinson\u2019s disease patients. Mov Disord Off J Mov Disord Soc 8:380\u2013382. https:\/\/doi.org\/10.1002\/mds.870080326","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3238_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14802\/jmd.23130","volume":"17","author":"JY Joo","year":"2024","unstructured":"Joo JY, Yun JY, Kim YE et al (2024) A Survey of Perspectives on Telemedicine for Patients With Parkinson\u2019s Disease. J Mov Disord 17:89\u201393. https:\/\/doi.org\/10.14802\/jmd.23130","journal-title":"J Mov Disord"},{"key":"3238_CR42","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet Lond Engl 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet Lond Engl"},{"key":"3238_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1017\/S0266462311000638","volume":"28","author":"K Kidholm","year":"2012","unstructured":"Kidholm K, Ekeland AG, Jensen LK et al (2012) A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care 28:44\u201351. https:\/\/doi.org\/10.1017\/S0266462311000638","journal-title":"Int J Technol Assess Health Care"},{"key":"3238_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1109\/IEMBS.2008.4649273","volume":"2008","author":"GV Kondraske","year":"2008","unstructured":"Kondraske GV, Stewart RM (2008) Web-based evaluation of Parkinson\u2019s disease subjects: objective performance capacity measurements and subjective characterization profiles. Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Int Conf 2008:799\u2013802. https:\/\/doi.org\/10.1109\/IEMBS.2008.4649273","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Int Conf"},{"key":"3238_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40273-021-01011-y","volume":"39","author":"C Kruse","year":"2021","unstructured":"Kruse C, Kretschmer S, Lipinski A et al (2021) Resource Utilization of Patients with Parkinson\u2019s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study. PharmacoEconomics 39:601\u2013615. https:\/\/doi.org\/10.1007\/s40273-021-01011-y","journal-title":"PharmacoEconomics"},{"key":"3238_CR46","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1055\/s-0042-1758751","volume":"80","author":"DP Lima","year":"2022","unstructured":"Lima DP, Gomes VC, Viana J\u00fanior AB et al (2022) Telehealth for Parkinson disease patients during the COVID-19 pandemic: the TeleParkinson study. Arq Neuropsiquiatr 80:1026\u20131035. https:\/\/doi.org\/10.1055\/s-0042-1758751","journal-title":"Arq Neuropsiquiatr"},{"key":"3238_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/mds.10119","volume":"17","author":"ED Louis","year":"2002","unstructured":"Louis ED, Levy G, C\u00f4te LJ et al (2002) Diagnosing Parkinson\u2019s disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Mov Disord Off J Mov Disord Soc 17:513\u2013517. https:\/\/doi.org\/10.1002\/mds.10119","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3238_CR48","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00702-023-02697-4","volume":"130","author":"M Magri\u00e7o","year":"2023","unstructured":"Magri\u00e7o M, Ser\u00f4dio M, Ventura R, Bugalho P (2023) Parkinson\u2019s disease patients\u2019 perspective on telephone visits during the COVID-19 pandemic. J Neural Transm Vienna Austria 1996 130:1547\u20131551. https:\/\/doi.org\/10.1007\/s00702-023-02697-4","journal-title":"J Neural Transm Vienna Austria 1996"},{"key":"3238_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/tmj.2017.0119","volume":"24","author":"JR Mammen","year":"2018","unstructured":"Mammen JR, Elson MJ, Java JJ et al (2018) Patient and Physician Perceptions of Virtual Visits for Parkinson\u2019s Disease: A Qualitative Study. Telemed J E-Health Off J Am Telemed Assoc 24:255\u2013267. https:\/\/doi.org\/10.1089\/tmj.2017.0119","journal-title":"Telemed J E-Health Off J Am Telemed Assoc"},{"key":"3238_CR50","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1258\/jtt.2012.120105","volume":"18","author":"F Marzinzik","year":"2012","unstructured":"Marzinzik F, Wahl M, Doletschek CM et al (2012) Evaluation of a telemedical care programme for patients with Parkinson\u2019s disease. J Telemed Telecare 18:322\u2013327. https:\/\/doi.org\/10.1258\/jtt.2012.120105","journal-title":"J Telemed Telecare"},{"key":"3238_CR51","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.4103\/0028-3886.359193","volume":"70","author":"R-V Mayela","year":"2022","unstructured":"Mayela R-V, Yamil M, Amin C-A et al (2022) Satisfaction With Telemedicine Consultation as Follow-Up Visit in Patients with Parkinsonism and Essential Tremor in during the Covid-19 Pandemic. Neurol India 70:2003\u20132008. https:\/\/doi.org\/10.4103\/0028-3886.359193","journal-title":"Neurol India"},{"issue":"10","key":"3238_CR52","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synthesis 18(10):2127\u20132133","journal-title":"JBI Evid Synthesis"},{"key":"3238_CR54","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.prdoa.2021.100094","volume":"4","author":"TL Myers","year":"2021","unstructured":"Myers TL, Tarolli CG, Adams JL et al (2021) Video-based Parkinson\u2019s disease assessments in a nationwide cohort of Fox Insight participants. Clin Park Relat Disord 4:100094. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100094","journal-title":"Clin Park Relat Disord"},{"key":"3238_CR53","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/JPD-212935","volume":"12","author":"TL Myers","year":"2022","unstructured":"Myers TL, Augustine EF, Baloga E et al (2022) Recruitment for Remote Decentralized Studies in Parkinson\u2019s Disease. J Park Dis 12:371\u2013380. https:\/\/doi.org\/10.3233\/JPD-212935","journal-title":"J Park Dis"},{"key":"3238_CR55","volume-title":"Parkinson\u2019s disease in adults: diagnosis and management: full guideline","author":"National Institute for Health and Care Excellence","year":"2017","unstructured":"National Institute for Health and Care Excellence (2017) Parkinson\u2019s disease in adults: diagnosis and management: full guideline. National Institute for Health and Care Excellence, London"},{"key":"3238_CR56","doi-asserted-by":"publisher","unstructured":"Ogawa M, Oyama g, Sekimoto S et al (2022) Current Status of Telemedicine for Parkinson\u2019s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey. J Mov Disord 15. https:\/\/doi.org\/10.14802\/jmd.21096","DOI":"10.14802\/jmd.21096"},{"key":"3238_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41531-023-00523-y","volume":"9","author":"C Pearson","year":"2023","unstructured":"Pearson C, Hartzman A, Munevar D et al (2023) Care access and utilization among medicare beneficiaries living with Parkinson\u2019s disease. NPJ Park Dis 9:108. https:\/\/doi.org\/10.1038\/s41531-023-00523-y","journal-title":"NPJ Park Dis"},{"key":"3238_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.irn.2022.04.002","volume":"165","author":"AM Podlewska","year":"2022","unstructured":"Podlewska AM, van Wamelen DJ (2022) Parkinson\u2019s disease and Covid-19: The effect and use of telemedicine. Int Rev Neurobiol 165:263\u2013281. https:\/\/doi.org\/10.1016\/bs.irn.2022.04.002","journal-title":"Int Rev Neurobiol"},{"key":"3238_CR59","unstructured":"Protection of Personal Information Act (2013) Protection of Personal Information Act"},{"key":"3238_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.parkreldis.2015.02.018","volume":"21","author":"JK Qiang","year":"2015","unstructured":"Qiang JK, Marras C (2015) Telemedicine in Parkinson\u2019s disease: A patient perspective at a tertiary care centre. Parkinsonism Relat Disord 21:525\u2013528. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.018","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR61","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/healthcare10061065","volume":"10","author":"F Ruggiero","year":"2022","unstructured":"Ruggiero F, Lombi L, Molisso MT et al (2022) The Impact of Telemedicine on Parkinson\u2019s Care during the COVID-19 Pandemic: An Italian Online Survey. Healthc Basel Switz 10:1065. https:\/\/doi.org\/10.3390\/healthcare10061065","journal-title":"Healthc Basel Switz"},{"key":"3238_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11920-021-01274-4","volume":"23","author":"SA Saeed","year":"2021","unstructured":"Saeed SA, Masters RM (2021) Disparities in Health Care and the Digital Divide. Curr Psychiatry Rep 23:61. https:\/\/doi.org\/10.1007\/s11920-021-01274-4","journal-title":"Curr Psychiatry Rep"},{"key":"3238_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1258\/135763306775321371","volume":"12","author":"A Samii","year":"2006","unstructured":"Samii A, Ryan-Dykes P, Tsukuda RA et al (2006) Telemedicine for delivery of health care in Parkinson\u2019s disease. J Telemed Telecare 12:16\u201318. https:\/\/doi.org\/10.1258\/135763306775321371","journal-title":"J Telemed Telecare"},{"key":"3238_CR64","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1055\/s-0042-1755323","volume":"80","author":"DT Santos","year":"2022","unstructured":"Santos DT, Camelo DMF, Strelow MZ et al (2022) Feasibility of telemedicine for patients with parkinsonism in the Brazilian public health system. Arq Neuropsiquiatr 80:914\u2013921. https:\/\/doi.org\/10.1055\/s-0042-1755323","journal-title":"Arq Neuropsiquiatr"},{"key":"3238_CR65","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/WNL.0b013e31822c9123","volume":"77","author":"M Schootman","year":"2011","unstructured":"Schootman M, Evanoff BA, Perlmutter JS, Racette BA (2011) Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology 77:851\u2013857. https:\/\/doi.org\/10.1212\/WNL.0b013e31822c9123","journal-title":"Neurology"},{"key":"3238_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/SHTT.S75184","volume":"3","author":"RE Scott","year":"2015","unstructured":"Scott RE, Mars M (2015) Telehealth in the developing world: current status and future prospects. Smart Homecare Technol TeleHealth 3:25\u201337. https:\/\/doi.org\/10.2147\/SHTT.S75184","journal-title":"Smart Homecare Technol TeleHealth"},{"key":"3238_CR67","doi-asserted-by":"publisher","first-page":"9403295","DOI":"10.1155\/2019\/9403295","volume":"2019","author":"S Sekimoto","year":"2019","unstructured":"Sekimoto S, Oyama G, Hatano T et al (2019) A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson\u2019s Disease. Park Dis 2019:9403295. https:\/\/doi.org\/10.1155\/2019\/9403295","journal-title":"Park Dis"},{"key":"3238_CR68","doi-asserted-by":"publisher","first-page":"582613","DOI":"10.3389\/fneur.2020.582613","volume":"11","author":"A Shalash","year":"2020","unstructured":"Shalash A, Fathy M, Dawood NL, Hamid E (2020) Adopting Virtual Visits for Parkinson\u2019s Disease Patients During the COVID-19 Pandemic in a Developing Country. Front Neurol 11:582613. https:\/\/doi.org\/10.3389\/fneur.2020.582613","journal-title":"Front Neurol"},{"key":"3238_CR69","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-202411","volume":"11","author":"A Shalash","year":"2021","unstructured":"Shalash A, Spindler M, Cubo E (2021) Global Perspective on Telemedicine for Parkinson\u2019s Disease. J Park Dis 11:S11\u2013S18. https:\/\/doi.org\/10.3233\/JPD-202411","journal-title":"J Park Dis"},{"key":"3238_CR70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.parkreldis.2021.03.032","volume":"86","author":"V Shivkumar","year":"2021","unstructured":"Shivkumar V, Subramanian T, Agarwal P et al (2021) Uptake of telehealth in Parkinson\u2019s disease clinical care and research during the COVID-19 pandemic. Parkinsonism Relat Disord 86:97\u2013100. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.032","journal-title":"Parkinsonism Relat Disord"},{"key":"3238_CR71","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/tmj.2011.0276","volume":"18","author":"D Shprecher","year":"2012","unstructured":"Shprecher D, Noyes K, Biglan K et al (2012) Willingness of Parkinson\u2019s disease patients to participate in research using internet-based technology. Telemed J E-Health Off J Am Telemed Assoc 18:684\u2013687. https:\/\/doi.org\/10.1089\/tmj.2011.0276","journal-title":"Telemed J E-Health Off J Am Telemed Assoc"},{"key":"3238_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JPD-181557","volume":"9","author":"KL Spear","year":"2019","unstructured":"Spear KL, Auinger P, Simone R et al (2019) Patient Views on Telemedicine for Parkinson Disease. J Park Dis 9:401\u2013404. https:\/\/doi.org\/10.3233\/JPD-181557","journal-title":"J Park Dis"},{"key":"3238_CR73","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"3238_CR74","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.25814","volume":"29","author":"CM Tanner","year":"2014","unstructured":"Tanner CM, Meng CC, Ravina B et al (2014) A practical approach to remote longitudinal follow-up of Parkinson\u2019s disease: the FOUND study. Mov Disord Off J Mov Disord Soc 29:743\u2013749. https:\/\/doi.org\/10.1002\/mds.25814","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3238_CR75","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3233\/JPD-202163","volume":"10","author":"CG Tarolli","year":"2020","unstructured":"Tarolli CG, Andrzejewski K, Zimmerman GA et al (2020) Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson\u2019s Disease. J Park Dis 10:1779\u20131786. https:\/\/doi.org\/10.3233\/JPD-202163","journal-title":"J Park Dis"},{"key":"3238_CR76","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-0043-1768665","volume":"81","author":"D Teixeira-Dos-Santos","year":"2023","unstructured":"Teixeira-Dos-Santos D, Camelo DMF, Strelow MZ et al (2023) Feasibility for evaluating motor aspects of Parkinson\u2019s disease through video consultations in a resource-limited setting in Southern Brazil. Arq Neuropsiquiatr 81:444\u2013451. https:\/\/doi.org\/10.1055\/s-0043-1768665","journal-title":"Arq Neuropsiquiatr"},{"key":"3238_CR77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/WCO.0000000000000953","volume":"34","author":"R van den Bergh","year":"2021","unstructured":"van den Bergh R, Bloem BR, Meinders MJ, Evers LJW (2021) The state of telemedicine for persons with Parkinson\u2019s disease. Curr Opin Neurol 34:589\u2013597. https:\/\/doi.org\/10.1097\/WCO.0000000000000953","journal-title":"Curr Opin Neurol"},{"key":"3238_CR78","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk NM, de Vries NM, Kessels RPC et al (2019) Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol 18:998\u20131008. https:\/\/doi.org\/10.1016\/S1474-4422(19)30285-6","journal-title":"Lancet Neurol"},{"key":"3238_CR79","doi-asserted-by":"crossref","unstructured":"Van Dijk Jan AGM (2012) The Evolution of the Digital Divide: The digital divide turns to inequality of skills and Usage. In: Digital Enlightenment Yearbook 2012. IOS","DOI":"10.3233\/978-1-61499-057-4-57"},{"key":"3238_CR80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1212\/01.CPJ.0000437937.63347.5a","volume":"4","author":"V Venkataraman","year":"2014","unstructured":"Venkataraman V, Donohue SJ, Biglan KM et al (2014) Virtual visits for Parkinson disease: A case series. Neurol Clin Pract 4:146\u2013152. https:\/\/doi.org\/10.1212\/01.CPJ.0000437937.63347.5a","journal-title":"Neurol Clin Pract"},{"key":"3238_CR81","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1017\/cts.2022.459","volume":"6","author":"T Virmani","year":"2022","unstructured":"Virmani T, Lotia M, Glover A et al (2022) Feasibility of telemedicine research visits in people with Parkinson\u2019s disease residing in medically underserved areas. J Clin Transl Sci 6:e133. https:\/\/doi.org\/10.1017\/cts.2022.459","journal-title":"J Clin Transl Sci"},{"key":"3238_CR82","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1212\/CPJ.0000000000000252","volume":"6","author":"JR Wilkinson","year":"2016","unstructured":"Wilkinson JR, Spindler M, Wood SM et al (2016) High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study. Neurol Clin Pract 6:241\u2013251. https:\/\/doi.org\/10.1212\/CPJ.0000000000000252","journal-title":"Neurol Clin Pract"},{"key":"3238_CR32","unstructured":"World Health Organization (2021) Global Strategy on Digital Health 2020\u20132025, 1st edn. https:\/\/www.who.int\/publications\/i\/item\/9789240020924"},{"key":"3238_CR83","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/mds.28990","volume":"37","author":"Y Xu","year":"2022","unstructured":"Xu Y, Feeney MP, Surface M et al (2022) Attitudes Toward Telehealth Services Among People Living With Parkinson\u2019s Disease: A Survey Study. Mov Disord Off J Mov Disord Soc 37:1289\u20131294. https:\/\/doi.org\/10.1002\/mds.28990","journal-title":"Mov Disord Off J Mov Disord Soc"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03238-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:19:06Z","timestamp":1792577946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03238-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3238"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03238-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}